Literature DB >> 6537961

Isotypes of spontaneous and mitogen-induced autoantibodies in SLE-prone mice.

J H Slack, L Hang, J Barkley, R J Fulton, L D'Hoostelaere, A Robinson, F J Dixon.   

Abstract

A common cellular abnormality of all murine strains prone to systemic lupus erythematosus (SLE) is an increased spontaneous polyclonal expansion of B cells. Our findings support the existence of this SLE-associated abnormality because the numbers of B lymphocytes secreting all the different IgG subclasses and IgM in spleens of all lupus-prone mice are elevated, compared to levels of normal splenic immunoglobulin-producing cells. We also report that 1) spontaneous polyclonal stimulation of immunoglobulin in autoimmune mice is preferential for subclass, and that the preferentially stimulated isotypes in each SLE strain consistently dominate both circulating and kidney-deposited immune complexes; 2) distinct patterns of isotype preference exist among the autoimmune strains determined by inherent B cell proliferative abnormalities or by B cell proliferation affected by thymus-derived lymphocytes; and 3) chronic administration of the TI B cell mitogen Lipid A in late-life SLE-prone mice induces an early-life glomerulonephritis with auto-antibodies of an isotype composition characteristic of those spontaneously produced by inherently abnormal B cells of early-life lupus mice.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6537961

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

1.  Fc gamma RIII and Fc gamma RIV are indispensable for acute glomerular inflammation induced by switch variant monoclonal antibodies.

Authors:  Angela Giorgini; Heather J Brown; Helen R Lock; Falk Nimmerjahn; Jeffrey V Ravetch; J Sjef Verbeek; Steven H Sacks; Michael G Robson
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

2.  Qualitative difference of anti-DNA antibody-producing cell precursors in the pre-immune B cell repertoire between normal and lupus-prone mice.

Authors:  K Iwai; T Tsubata; Y Katsura; S Kumagai; H Imura
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330

3.  B cell repertoire for anti-DNA antibody in normal and lupus mice: differential expression of precursor cells for high and low affinity anti-DNA antibodies.

Authors:  T Tsubata; S Nishikawa; Y Katsura; S Kumagai; H Imura
Journal:  Clin Exp Immunol       Date:  1988-01       Impact factor: 4.330

4.  Molecular genetics of murine lupus.

Authors:  A N Theofilopoulos
Journal:  Agents Actions       Date:  1986-12

Review 5.  Molecular aspects of murine systemic lupus erythematosus.

Authors:  A N Theofilopoulos; R Kofler; D Noonan; P Singer; F J Dixon
Journal:  Springer Semin Immunopathol       Date:  1986

6.  Somatic mutation of the T15 heavy chain gives rise to an antibody with autoantibody specificity.

Authors:  B Diamond; M D Scharff
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

7.  IL-21 receptor is required for the systemic accumulation of activated B and T lymphocytes in MRL/MpJ-Fas(lpr/lpr)/J mice.

Authors:  Andrew L Rankin; Heath Guay; Deborah Herber; Sarah A Bertino; Tatyana A Duzanski; Yijun Carrier; Sean Keegan; Mayra Senices; Nancy Stedman; Mark Ryan; Laird Bloom; Quintus Medley; Mary Collins; Cheryl Nickerson-Nutter; Joe Craft; Deborah Young; Kyri Dunussi-Joannopoulos
Journal:  J Immunol       Date:  2012-01-09       Impact factor: 5.422

8.  Autoreactivity to mouse C1q in a murine model of SLE.

Authors:  P K Trinder; M J Maeurer; H U Schorlemmer; M Loos
Journal:  Rheumatol Int       Date:  1995       Impact factor: 2.631

9.  The type of dietary fat affects the severity of autoimmune disease in NZB/NZW mice.

Authors:  N J Alexander; N L Smythe; M P Jokinen
Journal:  Am J Pathol       Date:  1987-04       Impact factor: 4.307

10.  Induction of persistent autoimmune haemolytic anaemia in mice by combined use of rat erythrocyte preimmunization and chronic GVHR.

Authors:  S Negoro; T Takashima; H Toba; S Kishimoto
Journal:  Immunology       Date:  1985-12       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.